Injectable Drug Delivery Devices Market 2018 to Foresee Growth with an Estimated USD 350.2 Billion in 2016 | CAGR of 11.8% | Forecast to 2023

MarketResearchFuture.com adds “Injectable Drug Delivery Devices Market -2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

Regional analysis:
Global injectable drug delivery devices market is dominated by America owning to increasing patient population suffering from diabetes and cancer. Increasing aging population and technological development is also supporting the growth of the market. Europe accounts second largest market for injectable drug delivery devices which is followed by Asia Pacific. Huge patient population and rapid development of economies in countries of Asia Pacific is the major driver for the market in this region.

The report for global injectable drug delivery devices market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Key players for global injectable drug delivery devices market:
The major key player for the global injectable drug delivery devices market are Becton, Dickinson and Company (US), Baxter International (US), Schott AG (Germany), Eli Lilly and Company (US), Pfizer (US), Gerresheimer AG (Germany), Terumo Corporation (Japan), Antares Pharma, Inc. (US), Novo Nordik (Denmark), Sanofi SA (France), Unilife Corporation (US), Zogenix, Inc (US), Hospira, Inc (US), Presage Bioscience (US), MicroCHIPS, Inc (US), Pearl Therapeutics Inc (US), Genentech Inc. (US), Bend Research (US)

Market Highlights
The injectable drug delivery devices are used to deliver the medication into the blood stream. The injectable drug delivery devices market is estimated to grow at a CAGR of 11.8% owning to increasing prevalence of cancer and diabetes. According to WHO, The number of people with diabetes had risen to 422 million in 2014 , 14.1 million cancer cases was registered around the world in 2012 and this  is expected to increase up to 24 million by 2035. Increasing prevalence of other chronic diseases, technological advances and many advantages of the injectable drug delivery method has uplifted the growth of the market. However, availability of alternative delivery devices and high risk of blood-borne infections have restrained the growth of the market.

The injectable drug delivery devices market was estimated at $ 350.2 billion in 2016.

TRY SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/1211 .

Competitive Analysis:
Global injectable drug delivery devices market is saturated by the presence of a number of small and medium sized companies. Some of them are focusing on the development of new products for the treatment, while some of leading companies in this market are collaborating with local companies in order to minimize the competition and increase the product range

Becton, Dickinson and Company is an America multination company headquartered in New Jersey. 60% of company sales were generated from non-U.S. markets. As company is trying to develop their market in other countries. Company has launched a number of products like insulin pen and other injectable needles. HyFlow is the self-injection with thin wall needle used in the delivery of highly viscous drug formulations. Physioject, Libertas, Intevia are some of the auto injector manufactured by the company. There is 4% grow in the company’s market in 2016.

Eli Lilly and Company is an US headquartered. Company is focusing on development of new innovation center with a focus on drug delivery devices. It is expected to double its revenues from device-enabled products by 2020.

Segmentation:
Global injectable drug delivery devices market is segmented on the basis of type into devices and formulation. Devices are further segmented into self- injection devices and conventional injection devices. By formulation, they are sub segmented into conventional drug delivery, novel drug delivery and others. On the basis of application, the market is segmented into immune disorder, cancer, diabetes, and other. And on the basis of end users the market is segmented into hospitals, homecare, clinics, and other.

BRIEF TOC:
Chapter 1. INTRODUCTION

1.1 DEFINITION          

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE      

1.2.2 ASSUMPTIONS & LIMITATIONS        

1.2.2.1 ASSUMPTIONS    

1.2.2.2 LIMITATIONS        

1.3 MARKET STRUCTURE:       

Chapter 2. RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:        

2.2 PRIMARY RESEARCH         

2.3 SECONDARY RESEARCH:  

Chapter 3. MARKET DYNAMICS

3.1 DRIVERS       

3.2 RESTRAINTS

3.3 OPPORTUNITIES  

3.4 MACROECONOMIC INDICATORS     

Chapter 4. MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL       

4.2 BARGAINING POWER OF SUPPLIERS              

4.3 BARGAINING POWER OF BUYERS   

4.4 THREAT OF NEW ENTRANTS            

4.5 THREAT OF SUBSTITUTES  

4.6 INTENSITY OF RIVALRY

Chapter 5. GLOBAL INJECTABLE DRUG DELIVERY DEVICES, BY ROUTE OF ADMINISTRATION

5.1 INTRAVENOUS

5.2 INTRAMUSCULAR

5.3 INTRA-ARTERIAL

5.4 INTRA-THECAL

5.5 OTHERS

…CONTINUED

AVAIL DISCOUNT REPORT @ https://www.marketresearchfuture.com/check-discount/1211 .

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: 
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, 
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com